|
Characterization of cell lines used in training and validation |
|||||||
| Affymetrix U133A chips |
|||||||
|
|
|||||||
| Cell Line |
Type |
Sensitivity to EGFR TKI |
K-Ras Status |
(n) in training |
(n) in validation |
EGFR Status |
|
|
|
|||||||
| Training |
A549 |
AC |
No |
Mutant (Codon 12) |
8 |
N/A |
Wt 1 |
| UKY-29 |
AC |
No |
Mutant (Codon 61)1 |
3 |
N/A |
Wt 1 |
|
| H1650 |
AC |
Yes |
Wt |
6 |
N/A |
Mutant (DelE746-A750)1 |
|
| PC-9 |
AC |
Yes |
Wt |
5 |
N/A |
Mutant (DelE746-A750)1 |
|
| H3255 |
AC |
Yes |
Wt |
3 |
N/A |
Mutant (L858R) 1 |
|
|
|
|||||||
| Validation |
H358 |
AC |
Yes |
Mutant (Codon 12) |
0 |
1 |
Wt1 |
| H460 |
Large Cell |
No |
Mutant (Codon 61) |
0 |
1 |
Wt1 |
|
| H1975 |
AC |
No |
Wt |
0 |
1 |
Mutant (L858R, T790M) 1 |
|
| K562 |
CML |
No |
Wt |
0 |
1 |
Wt1 |
|
| A431 |
Epidermoid |
Yes |
Wt |
0 |
1 |
Wt (Amplified)1 |
|
|
1 Assayed in this study AC: Adenocarcinoma CML: Chronic Myelogenous Leukemia | |||||||
Balko et al. BMC Genomics 2006 7:289 doi:10.1186/1471-2164-7-289 |
|||||||